Cannabinoid receptor 2 augments eosinophil responsiveness and aggravates allergen‐induced pulmonary inflammation in mice von Frei, R. B., Luschnig, P., Parzmair, G. P., Peinhaupt, M., Schranz, S., Fauland, A., Wheelock, C. E., Heinemann, A., Sturm, E. M.

Volltext

Cannabinoid receptor 2 augments eosinophil responsiveness and aggravates allergen-induced pulmonary inflammation in mice von Frei-Winterleitner, RB, Luschnig, P, Parzmair, GP, Peinhaupt, M, Schranz, S, Fauland, A, Wheelock, CE, Heinemann, A, Sturm, EM

Volltext

Results of the phase-I open-label clinical trial SAKK 06/14 assessing safety of intravesical instillation of the recombinant BCG VPM1002BC in patients with non-muscle invasive blad... von Rentsch, C., Bosshard, P., Mayor, G., Rieken, M., Püschel, H., Wirth, G., Cathomas, R., Grode, L., Parzmair, G., Eisele, B., Sharma, H., Shaligram, U., Goldenberger, D., Spertini, F., Audran, R., Enoui, M., Berardi-Vilei, S., Hayoz, S., Wicki, A.

Volltext

728 - Results of the phase-I open-label clinical trial SAKK 06/14 assessing safety of intravesical instillation of the recombinant BCG VPM1002BC in patients with non-muscle invasiv... von Rentsch, C., Bosshard, P., Mayor, G., Rieken, M., Püschel, H., Wirth, G., Cathomas, R., Grode, L., Parzmair, G., Eisele, B., Sharma, H., Shaligram, U., Goldenberger, D., Spertini, F., Audran, R., Enoui, M., Berardi-Vilei, S., Hayoz, S., Wicki, A.

Volltext

VPM1002 as Prophylaxis Against Severe Respiratory Tract Infections Including Coronavirus Disease 2019 in the Elderly: A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multic... von Blossey, Alexandra M, Brückner, Sina, May, Marcus, Parzmair, Gerald P, Sharma, Hitt, Shaligram, Umesh, Grode, Leander, Kaufmann, Stefan H E, Netea, Mihai G, Schindler, Christoph

Volltext